Febuxostat: A Review of Its Use in the Treatment of Hyperuricaemia in Patients with Gout
出版年份 2015 全文链接
标题
Febuxostat: A Review of Its Use in the Treatment of Hyperuricaemia in Patients with Gout
作者
关键词
Gout, Allopurinol, Febuxostat, Moderate Renal Impairment, Xanthine Oxidase Inhibitor
出版物
DRUGS
Volume 75, Issue 4, Pages 427-438
出版商
Springer Nature
发表日期
2015-02-27
DOI
10.1007/s40265-015-0360-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SAT0531 Updated Eular Evidence-Based Recommendations for the Management of Gout
- (2014) P. Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Febuxostat: drug review and update
- (2014) Harmanjot K Grewal et al. Expert Opinion on Drug Metabolism & Toxicology
- An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia
- (2014) Xinfang Huang et al. International Journal of Rheumatic Diseases
- Optimizing current treatment of gout
- (2014) Frances Rees et al. Nature Reviews Rheumatology
- Achieving Serum Urate Goal: A Comparative Effectiveness Study between Allopurinol and Febuxostat
- (2014) Hind Hatoum et al. POSTGRADUATE MEDICINE
- Emerging Therapies for Gout
- (2014) N. Lawrence Edwards et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
- (2014) T. M. MacDonald et al. BMJ Open
- Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
- (2013) Francisca Sivera et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients With or Without Gout: A Systematic Review and Meta-Analysis
- (2013) Peng Ye et al. CLINICAL THERAPEUTICS
- Safety profile of anti-gout agents
- (2013) Lisa K. Stamp CURRENT OPINION IN RHEUMATOLOGY
- A Revised Estimate of the Burden of Illness of Gout
- (2013) Albert Wertheimer et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Diabetes and gout: efficacy and safety of febuxostat and allopurinol
- (2013) M. A. Becker et al. DIABETES OBESITY & METABOLISM
- Preservation of Renal Function during Gout Treatment with Febuxostat: A Quantitative Study
- (2013) Andrew Whelton et al. POSTGRADUATE MEDICINE
- Gout
- (2013) E. Roddy et al. BMJ-British Medical Journal
- CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
- (2012) William B. White et al. AMERICAN HEART JOURNAL
- African American patients with gout: efficacy and safety of febuxostat vs allopurinol
- (2012) Alvin F Wells et al. BMC MUSCULOSKELETAL DISORDERS
- The effects of xanthine oxidase inhibition by febuxostat on the pharmacokinetics of theophylline
- (2012) Max Tsai et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Renal Function in Gout
- (2012) Andrew Whelton et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- An Allopurinol-Controlled, Randomized, Double-Dummy, Double-Blind, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan
- (2012) Naoyuki Kamatani et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Placebo-Controlled Double-Blind Dose-Response Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia (Including Gout Patients) in Japan
- (2012) Kamatani Naoyuki et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Placebo-Controlled, Double-Blind Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia Including Those With Gout in Japan
- (2012) Kamatani Naoyuki et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- PSY28 Cost-Effectiveness of Febuxostat in Managing Hyperuricemia in Gout Patients in Spain
- (2012) M. Cuesta et al. VALUE IN HEALTH
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
- (2012) Robert L Jackson et al. BMC Geriatrics
- Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
- (2011) Robert L. Wortmann et al. CLINICAL THERAPEUTICS
- Treating Hyperuricemia of Gout: Safety and Efficacy of Febuxostat and Allopurinol in Older Versus Younger Subjects
- (2011) Michael A. Becker et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Women with gout: Efficacy and safety of urate-lowering with febuxostat and allopurinol
- (2011) Saima Chohan et al. ARTHRITIS CARE & RESEARCH
- Febuxostat: A selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout
- (2010) Michael E. Ernst et al. CLINICAL THERAPEUTICS
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- (2010) Michael A Becker et al. ARTHRITIS RESEARCH & THERAPY
- Gout – what are the treatment options?
- (2009) Naomi Schlesinger et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
- (2009) M. A. BECKER et al. JOURNAL OF RHEUMATOLOGY
- Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
- (2009) H. R. Schumacher et al. RHEUMATOLOGY
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
- (2008) H. RALPH Schumacher et al. ARTHRITIS AND RHEUMATISM
- Febuxostat
- (2008) Philip I Hair et al. DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now